Complete remission at 8 weeks with high-dose adrenomedullin in UC

Complete remission at 8 weeks was observed in patients with steroid-resistant ulcerative colitis who received a high dose of adrenomedullin, according to study published in The Journal of Gastroenterology.“[Despite] the limited number of patients in this double-blind randomized trial, we observed the successful complete remission at 8 weeks in patients with steroid-resistant UC receiving a high dose of [adrenomedullin(AM)],” Toshihiro Kita, MD, from the division of circulatory and body fluid regulation, department of internal medicine, faculty of medicine at the University ofRead More

Share on facebook
Share on twitter
Share on linkedin